Compound ID | 188
Class: Quorum-sensing inhibitor
Spectrum of activity: | Gram-positive |
Details of activity: | Staphylococcus aureus, invasive skin and soft tissue infections (SSTIs) |
Institute where first reported: | Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA |
Year first mentioned: | 2015 |
Highest developmental phase: | Preclinical |
Development status: | Active |
External links: | |
Guide to Pharmacology: | ω-Hydroxyemodin |
Citation: | http://aac.asm.org/content/59/4/2223.full |